General Information of the Compound
Compound ID
CP0561503
Compound Name
5-bromo-4-[4-(1-phenylethyl)piperazin-1-yl]-1H-pyridazin-6-one
    Show/Hide
Structure
Formula
C16H19BrN4O
Molecular Weight
363.259
Canonical SMILES
CC(N1CCN(CC1)c1cn[nH]c(=O)c1Br)c1ccccc1
    Show/Hide
InChI
InChI=1S/C16H19BrN4O/c1-12(13-5-3-2-4-6-13)20-7-9-21(10-8-20)14-11-18-19-16(22)15(14)17/h2-6,11-12H,7-10H2,1H3,(H,19,22)
    Show/Hide
InChIKey
RINUCCVFNORVNO-UHFFFAOYSA-N
Physicochemical Property
logP
2.4156
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
52.23
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 142546650
ChEMBL ID
CHEMBL4592027
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 8800 nM
   TI
   LI
   LO
   TS